CFTR在眼部的作用及早期高效囊性纤维化跨膜传导调节因子调节剂治疗对囊性纤维化眼健康的影响
囊性纤维化跨膜传导调节因子(CFTR)在包括眼在内的多器官发育中起作用,其功能障碍导致囊性纤维化(CF)。高效CFTR调节剂疗法(如elexacaftor-tezacaftor-ivacaftor)已革新CF管理,但眼部影响在临床研究中多被忽视,仅有少数病例报告提示儿童及母婴暴露者出现晶状体病变。本综述总结CFTR在眼部的作用及其对后期眼功能与视力的潜在影响,为理解CFTR调节剂治疗的眼健康效应及利用眼部进行无创诊断监测提供框架。
要点
- CFTR在胚胎发育期即表达于眼等多个组织,其表达受遗传和环境因素影响。
- 高效CFTR调节剂疗法革新CF管理,但眼部影响在临床研究中多被忽视。
- 少数病例报告提示接受CFTR调节剂的幼儿及孕期暴露的母乳喂养婴儿出现晶状体病变。
核心结论
- CFTR在眼部发育和功能中起作用,CFTR调节剂治疗对眼健康的潜在影响值得关注,眼部或可作为CF患者无创诊断和监测的窗口。
研究设计与样本
- 综述,总结CFTR在眼部的作用及CFTR调节剂治疗对眼健康影响的现有证据。
主要发现
- CFTR在胚胎发育期表达于包括眼在内的多种组织,其表达受遗传和环境因素影响。
- 高效CFTR调节剂疗法(如elexacaftor-tezacaftor-ivacaftor)通过纠正分子缺陷革新CF管理,改善患者结局和预期寿命。
- 临床研究大多忽视CFTR调节剂治疗的眼部扰动,仅有少数病例报告描述接受调节剂的幼儿及孕期暴露的母乳喂养婴儿出现晶状体病变。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cystic fibrosis transmembrane conductance regulator (CFTR) is a protein that plays a crucial role in various human organs, including the respiratory and digestive systems. Dysfunctional CFTR is the key variant of the lethal genetic disorder, cystic fibrosis (CF). In the past decade, highly effective CFTR modulator therapies, including elexacaftor-tezacaftor-ivacaftor, have revolutionised CF management by correcting the underlying molecular defect to improve patient outcomes and life expectancy. Despite demonstrating multiorgan efficacy, clinical studies have largely overlooked the potential for ocular disturbances with CFTR modulator therapy, with the exception of a few case studies reporting the presence of crystalline lens pathologies in young children on CFTR modulators, and in breastfed infants born to individuals who were on CFTR modulator treatment during pregnancy. CFTR is present in multiple tissues during embryonic development, including the eye, and its expression can be influenced by genetic and environmental factors. This review summarises the role of CFTR in the eye, and the potential impact of CFTR on eye function and vision later in life. This information provides a framework for understanding the use and possible effects of CFTR-modulating therapeutics in the context of eye health, including the potential to leverage the eye for non-invasive and accessible diagnostic and monitoring capabilities in patients with CF.
引用
- Schneider-Futschik EK, Zhu Y, Li D, et al. The role of CFTR in the eye, and the effect of early highly effective modulator treatment for cystic fibrosis on eye health. Prog Retin Eye Res. 2024. PMID: 39245300. doi:10.1016/j.preteyeres.2024.101299
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。